Evidence map›Paper›PMID 41438989›Full record

ArticleFrontiers in oncology2025

Xiaoli Mei, Yanpeng Li, Shasha Xu, Xiaoping Shang, Bing Cheng, Xiaobo Niu, Xiaoting Liu, Yan Liu, Xinya Cheng, Xingmin Han and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Incidental detection of PDAC viaFrontiers in nuclear medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaoli MeiDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.
Yanpeng LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.
Shasha XuDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.
Xiaoping ShangDepartment of Medical Records, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bing ChengDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.
Xiaobo NiuDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.
Xiaoting LiuDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.
Yan LiuDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.
Xinya ChengFaculty of Arts and Social Science, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China.
Xingmin HanDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.
Ruihua WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Medical Key Laboratory of Molecular Imaging, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prostate-specific membrane antigen (PSMA) is expressed in hepatocellular carcinoma (HCC). Recently, Materials and Methods: Forty-four patients with suspected HCC undergoing both Results: Sixty-two intrahepatic lesions in 41 patients with HCC were finally involved in the statistical analysis. Conclusions:

Indexed as

18F-FDG18F-PSMA-1007diagnostic performanceshepatocellular carcinoma (HCC)prostate specific membrane antigen (PSMA)

Identifiers

PMID41438989
PMCPMC12719476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.